HSPA8 suppressed ferroptosis in liver cancer cells by upregulating the expression of SLC7A11/GPX4, decreasing erastin-mediated reactive oxygen species, and accumulating Fe2+ in cells in vitro and in vivo [238]. This evidence concerns the gene HSPA8 and liver cancer.